Title:
HBV INHIBITOR AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2021/093172
Kind Code:
A1
Abstract:
The present invention provides an anti-HBV compound, a pharmaceutically acceptable compound or stereoisomer thereof, a preparation method therefor, and use thereof for treating, eradicating or inhibiting HBV infection or for relieving liver damage caused by HBV infection.
Inventors:
GUO WEIBO (CN)
ZHANG DENGKE (CN)
JIN WEILI (CN)
JI MINGZHE (CN)
ZHANG YANXIA (CN)
ZHANG DENGKE (CN)
JIN WEILI (CN)
JI MINGZHE (CN)
ZHANG YANXIA (CN)
Application Number:
PCT/CN2020/073160
Publication Date:
May 20, 2021
Filing Date:
January 20, 2020
Export Citation:
Assignee:
XIAN XINTONG PHARMACEUTICAL RES CO LTD (CN)
International Classes:
C07D207/323; A61K31/341; A61K31/381; A61K31/4025; A61P1/16; A61P31/12; C07D207/33; C07D307/36; C07D307/38; C07D333/08
Domestic Patent References:
| WO2015011281A1 | 2015-01-29 | |||
| WO2017156255A1 | 2017-09-14 | |||
| WO2018039531A1 | 2018-03-01 | |||
| WO2018121689A1 | 2018-07-05 | |||
| WO2019165374A1 | 2019-08-29 | |||
| WO2019154343A1 | 2019-08-15 | |||
| WO2019118358A1 | 2019-06-20 | |||
| WO2019185016A1 | 2019-10-03 | |||
| WO2017156255A1 | 2017-09-14 |
Foreign References:
| CN108047115A | 2018-05-18 | |||
| CN109790168A | 2019-05-21 | |||
| CN109153640A | 2019-01-04 | |||
| CN108250122A | 2018-07-06 |
Other References:
See also references of EP 3919474A4
Attorney, Agent or Firm:
RUNWEN PATENT LAW FIRM (CN)
Download PDF:
Previous Patent: MONITORING METHOD, SYSTEM AND DEVICE, AND STORAGE MEDIUM
Next Patent: METHOD FOR SLICE SPECIFIC INFORMATION
Next Patent: METHOD FOR SLICE SPECIFIC INFORMATION